Displaying archives for 2014 June:

Feds fund lung cancer research at New York Medical College

Posted by Samantha Powell on June 30th, 2014 |

New York Medical College in Valhalla has been awarded a $201,250 grant to study lung cancer formation and growth triggered by nickel compounds. The award from the National Institutes of Health was recently announced by U.S. Rep. Nita M. Lowey, the senior Democrat on the House Appropriations Committee from the 17th congressional district in Westchester […]

What Can Oncologists Learn From Social Media?

Posted by Samantha Powell on June 30th, 2014 |

Matthew Katz, MD, director of radiation oncology at Lowell General Hospital, describes the session he chaired during the 2014 ASCO Annual Meeting on the use of social media by oncologists. Dr. Katz discusses how he uses social media to learn more about patient perceptions of cancer, how to decide which outlets to utilize, and some […]

Larger Studies of Multiple Families Will Help Us Better Understand Inherited Risk of Lung Cancer.

Posted by Samantha Powell on June 27th, 2014 |

Larger Studies of Multiple Families Will Help Us Better Understand Inherited Risk of Lung Cancer.

Stand up for lung health and against lung cancer

Posted by Samantha Powell on June 26th, 2014 |

Every five minutes, a woman in the United States is diagnosed with lung cancer, including almost 17,000 each year from California. Half of these women will not be alive a year later, and two-thirds of women diagnosed never smoked or are former smokers. The American Lung Association is racing against the clock to save women’s […]

Is It Time To Ask a Disturbing Question About The Geographical Location of Cancer Clinical Trials?

Posted by Samantha Powell on June 25th, 2014 |

The genesis of this commentary is the recent publication of population-based survival outcomes associated with specific malignancies in various European countries.1 This analysis, which covered the years 1999 to 2007 revealed rather striking variation in the survival of patients with the specific cancers based on geographical location. For example, five-year survival in the United Kingdom […]

Lung cancer study of why young, healthy are stricken

Posted by Samantha Powell on June 24th, 2014 |

Natalie DiMarco’s only obvious risk factor for getting lung cancer was having lungs. DiMarco had been experiencing respiratory problems for months in 2010, but her doctors just assumed the mother of two had allergies. By the time she learned she had lung cancer, the disease had spread into her lymph nodes and reached the membranes […]

Ambitious ‘Lung-MAP’ Trial Aims to Evaluate Biomarkers and New Drugs in Squamous Cell Lung Cancer

Posted by Samantha Powell on June 23rd, 2014 |

This month, the National Cancer Institute (NCI), along with the FDA, the Southwest Oncology Group (SWOG), several private foundations and five pharmaceutical companies, launched a prospective, biomarker-driven study of new drugs for squamous cell lung cancer. The Lung-MAP trial is remarkable for its collaborative nature, and scope. The study will identify “actionable” molecular abnormalities in […]

Not just smokers: Every woman is at risk for lung cancer

Posted by Samantha Powell on June 23rd, 2014 |

Every five minutes, a woman in the United States is diagnosed with lung cancer, including nearly 2,000 this year from Arizona. Half of these women will not be alive a year later, and two-thirds of women diagnosed never smoked or are former smokers. The American Lung Association is racing against the clock to save women’s […]

Damon Runyon Cancer Research foundation awards $4M to 10 top young clinical investigators

Posted by Samantha Powell on June 23rd, 2014 |

The Damon Runyon Cancer Research Foundation named seven new Damon Runyon Clinical Investigators at its spring 2014 Clinical Investigator Award Committee review. The recipients of this prestigious three-year award are outstanding early career physician-scientists conducting patient-oriented cancer research at major research centers under the mentorship of the nation’s leading scientists and clinicians. Each will receive […]

Johnson & Johnson Innovation Announces Immuno-Oncology Lung Cancer Collaboration with the Dana-Farber Cancer Institute’s Belfer Institute for Applied Cancer Science

Posted by Samantha Powell on June 23rd, 2014 |

Johnson & Johnson Innovation, Boston and Janssen Biotech, Inc. today announced a three-year immuno-oncology lung cancer collaboration with the Dana-Farber Cancer Institute. Through the collaboration, Janssen scientists will work with the research team at Dana-Farber’s Belfer Institute for Applied Cancer Science to determine the clinical setting for certain immuno-oncology agents in Janssen’s lung cancer discovery […]